Trade Summary

5 days ago, Ticho Barry, serving as Chief Medical Officer at Stoke Therapeutics, Inc. (STOK), sold 2,243 shares at $32.79 per share, for a total transaction value of $73,548.00. Following this transaction, Ticho Barry now holds 36,621 shares of STOK.

This sale represents a 6.00% decrease in Ticho Barry's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 1, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 5, 2026, 4 days after the trade was made.

Stoke Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.